Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: Results of the "Probio-HIV" clinical trial

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  D'Ettorre, Gabriella ^a   Ceccarelli, Giancarlo ^a   Giustini, Noemi ^a   Serafino, Sara ^a   Calantone, Nina ^c   De Girolamo, Gabriella ^a   Bianchi, Luigi ^a   Bellelli, Valeria ^a   Ascoli Bartoli, Tommaso ^a   Marcellini, Sonia ^a   Turriziani, Ombretta ^b   Brenchley, Jason M ^c   Vullo, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; CD14 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; D DIMER; HLA DR ANTIGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROBIOTIC AGENT; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOLOGICAL PARAMETERS; IMMUNOREACTIVITY; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MALE; PILOT STUDY; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS INHIBITION; SERODIAGNOSIS; TREATMENT OUTCOME; AGING; CLINICAL TRIAL; COMPLICATION; DIET THERAPY; DRUG EFFECTS; DYSBIOSIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFLAMMATION; INTESTINE FLORA; MICROBIOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY;

ADULT; AGED; AGING; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; COMBINED MODALITY THERAPY; DYSBIOSIS; FEMALE; GASTROINTESTINAL MICROBIOME; HIV INFECTIONS; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROBIOTICS;

EID: 84945545407     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137200     Document Type: Article

References (34)

1. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al. (2003) Decline in the AIDS and death rates in the EuroSida study: an observational study. Lancet 362:22-29. PMID: 12853195
2. Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. (2013) HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 173:614-622. doi: 10.1001/jamainternmed.2013.3728 PMID: 23459863
3. Rodger AJ, Fox Z, Lundgren JD, Kuller LH, Boesecke C, Gey D, et al. (2009) Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 200:973-983. doi: 10.1086/605447 PMID: 19678756
4. Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La Rosa A, et al. (2010) Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 201:1788-1795. doi: 10.1086/652749 PMID: 20446848
5. French MA, King MS, Tschampa JM, da Silva BA, Landay AL (2009) Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. J Infect Dis 200:1212-1215. doi: 10.1086/605890 PMID: 19728788
6. Funderburg NT, Mayne E, Sieg SF, Asaad R, Jiang W, Kalinowska M, et al. (2010) Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood 115:161-167. doi: 10.1182/blood-2009-03-210179 PMID: 19828697
7. Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, Paiardini M, et al. (2010) Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoSPathog 6:e1001052.
8. Mehandru S, Poles MA, Tenner-Racz K, Jean-Pierre P, Manuelli V, Lopez P, et al. (2006) Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med 3:e484. PMID: 17147468
9. Mavigner M, Cazabat M, Dubois M, L'Faqihi FE, Requena M, Pasquier C, et al. (2012) Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest 122:62-69. doi: 10.1172/JCI59011 PMID: 22156200
10. Hunt PW, Sinclair E, Rodriguez B, Shive C, Clagett B, Funderburg N, et al. (2014) Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis 210 (8):1228-38. doi: 10.1093/infdis/jiu238 PMID: 24755434
11. Ipp H, Zemlin AE, Erasmus RT, Glashoff RH (2014) Role of inflammation in HIV-1 disease progression and prognosis. Crit Rev Clin Lab Sci 51:98-111. doi: 10.3109/10408363.2013.865702 PMID: 24479745
12. Wittkop L, Bitard J, Lazaro E, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (2013) Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infectedpatients: the ANRS CO3 Aquitaine Cohort. J InfectDis 207:622-627.
13. Prendergast A, Prado JG, Kang YH, Chen F, Riddell LA, Luzzi G, et al. (2010) HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS 24:491-502. doi: 10.1097/QAD.0b013e3283344895 PMID: 20071976
14. Brenchley JM, Douek DC (2008) HIV infection and the gastrointestinal immune system. Mucosal Immunol 1:23-30. doi: 10.1038/mi.2007.1 PMID: 19079157
15. Belmonte L, Olmos M, Fanin A, Parodi C, Baré P, Concetti H, et al. (2007) The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART. AIDS 21:2106-2108. PMID: 17885303
16. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, et al. (2003) Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77:11708-11717. PMID: 14557656
17. Cahn P, Ruxrungtham K, Gazzard B, Diaz RS, Gori A, Kotler DP, et al. (2013) The immunomodulatory nutritional intervention NR100157 reduced CD4+ T-cell decline and immune activation: a 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study). Clin Infect Dis 57:139-46. doi: 10.1093/cid/cit171 PMID: 23511299
18. Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, Mulder I, Lan A, Bridonneau C, et al. (2009) The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31:677-89. doi: 10.1016/j.immuni.2009.08.020 PMID: 19833089
19. d'Ettorre G, Paiardini M, Zaffiri L, Andreotti M, Ceccarelli G, Rizza C, et al. (2011) HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS. Curr HIV Res 9:148-153. PMID: 21457131
20. Lane HC (2010) Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation. Top HIV Med 18:2-6. PMID: 20305309
21. d'Ettorre G, Paiardini M, Ceccarelli G, Silvestri G, Vullo V (2011) HIV-associated immune activation: from bench to bedside. AIDS Res Hum Retroviruses 27:355-64. doi: 10.1089/aid.2010.0342 PMID: 21309730
22. de Roock S, van Elk M, van Dijk ME, Timmerman HM, Rijkers GT, Prakken BJ, et al. (2010) Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 40:103-10. doi: 10.1111/j.1365-2222.2009.03344.x PMID: 19817754
23. Monachese M, Cunningham-Rundles S, Diaz MA, Guerrant R, Hummelen R, Kemperman R, et al. (2011) Probiotics and prebiotics to combat enteric infections and HIV in the developing world: a consensus report. Gut Microbes. 2:198-207. PMID: 21804356
24. Gori A, Rizzardini G, Van't Land B, Amor KB, van Schaik J, Torti C, et al. (2011) Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial. Mucosal Immunol. 4:554-63. doi: 10.1038/mi.2011.15 PMID: 21525866
25. Hummelen R, Changalucha J, Butamanya NL, Koyama TE, Cook A, Habbema JD, et al. (2011) Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes. 2:80-5. PMID: 21637031
26. Irvine SL, Hummelen R, Hekmat S (2011) Probiotic yogurt consumption may improve gastrointestinal symptoms, productivity, and nutritional intake of people living with human immunodeficiency virus in Mwanza, Tanzania. Nutr Res. 31:875-881.
27. Sandler NG, Douek DC (2012) Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nature Reviews Microbiology 10: 655-666 doi: 10.1038/nrmicro2848 PMID: 22886237
28. Villar-García J, Hernández JJ, Güerri-Fernández R, González A, Lerma E, Guelar A, et al. (2015) Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial. J Acquir Immune Defic Syndr. 68:256-63. doi: 10.1097/QAI.0000000000000468 PMID: 25469528
29. Dai C, DZhao D-H, Jiang M (2012) VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways. Int J Molecular Medicine 29: 202-208.
30. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, et al. (2003) T cell Activation Is Associated with Lower CD4+ T Cell Gains in Human Immunodeficiency Virus-Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy. J Infect Diseases 187:1534-1543.
31. Smith K, Aga E, Bosch RJ, Connick E, Landay A, Kuritzkes D, et al. (2004) Long-Term Changes in Circulating CD4 T Lymphocytes in Virologically Suppressed Patients after 6 Years of Highly Active Antiretroviral Therapy. AIDS 18:1953-1956. PMID: 15353982
32. Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, et al. (2006) Determinants of CD4+ T Cell Recovery during Suppressive Antiretroviral Therapy: Association of Immune Activation, T Cell Maturation Markers, and Cellular HIV-1 DNA. J. Infect. Diseases 194:29-37.
33. Hunt PW (2012) HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep. 9:139-47. doi: 10.1007/s11904-012-0118-8 PMID: 22528766
34. Anukam KC, Osazuwa EO, Osadolor HB, Bruce AW, Reid G (2008) Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol 42:239-243.